Literature DB >> 27936768

Oligomerization Study of Human Organic Anion Transporting Polypeptide 1B1.

Chunxu Ni1, Xuan Yu1, Zihui Fang1, Jiujiu Huang1,2, Mei Hong1,2.   

Abstract

Organic anion-transporting polypeptides play important roles in the uptake of various endogenous and exogenous compounds. It has been proposed that OATP family members, as membrane proteins, may form oligomers. However, oligomerization status of OATPs is still largely unclear. In the present study, HEK293 cells stably expressing OATP1B1 were generated to investigate the oligomerization status of the transporter. Chemical cross-linking and coimmunoprecipitation experiments revealed that OATP1B1 may form homo-oligomers, possibly through disulfide bonds. When wild-type OATP1B1 was coexpressed with a loss-of-function mutant W258A, cells showed reduced uptake of prototypic substrate estrone-3-sulfate (ES). Interestingly, such a coexpression did not affect OATP1B1 transport activity of high concentrations ES, implicating that oligomerization status may affect only the high affinity component of ES. OATP1B1 possesses three GXXXG motifs that have been associated with protein dimerization in other membrane proteins. When glycine residues were replaced with alanine, G219A and G393A showed drastically reduced uptake function. Further studies revealed that G219A has a similar association capability to that of the wild-type, while mutation at Gly393 may affect oligomerization status of the transporter. Kinetic analysis showed that both G219A and G393A have a dramatically reduced Vmax for ES uptake. Km of G219A was increased while that of G393A exhibited a decreased value for high affinity component of ES binding. Our studies demonstrated that OATP1B1 may function as oligomers in the high affinity site of ES while acting as monomers for the low affinity binding component of the substrate.

Entities:  

Keywords:  GXXXG motif; drug transporter; oligomerization; organic anion transporting polypeptide; uptake function

Mesh:

Substances:

Year:  2017        PMID: 27936768     DOI: 10.1021/acs.molpharmaceut.6b00649

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  6 in total

Review 1.  Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.

Authors:  Michael Murray; Fanfan Zhou
Journal:  Br J Pharmacol       Date:  2017-04-24       Impact factor: 8.739

Review 2.  Post-translational regulation of the major drug transporters in the families of organic anion transporters and organic anion-transporting polypeptides.

Authors:  Wooin Lee; Jeong-Min Ha; Yuichi Sugiyama
Journal:  J Biol Chem       Date:  2020-10-13       Impact factor: 5.157

3.  The Importance of Val386 in Transmembrane Domain 8 for the Activation of OATP1B3 by Epigallocatechin Gallate.

Authors:  Zhongmin Wang; Ying Li; Cecilia E Villanueva; Taotao Peng; Wanjun Han; Zheyue Bo; Hongjian Zhang; Bruno Hagenbuch; Chunshan Gui
Journal:  J Agric Food Chem       Date:  2022-05-22       Impact factor: 5.895

Review 4.  Protein-protein interactions of drug uptake transporters that are important for liver and kidney.

Authors:  Yuchen Zhang; Bruno Hagenbuch
Journal:  Biochem Pharmacol       Date:  2019-08-02       Impact factor: 5.858

5.  Organic anion transporting polypeptide 1B3 can form homo- and hetero-oligomers.

Authors:  Yuchen Zhang; Kelli H Boxberger; Bruno Hagenbuch
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

6.  Alternative Splicing of the SLCO1B1 Gene: An Exploratory Analysis of Isoform Diversity in Pediatric Liver.

Authors:  Bianca D van Groen; Chengpeng Bi; Roger Gaedigk; Vincent S Staggs; Dick Tibboel; Saskia N de Wildt; J Steven Leeder
Journal:  Clin Transl Sci       Date:  2020-01-09       Impact factor: 4.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.